Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 0.84 |
| ▸ | CA1 | P00915 | 3/20 | 0.84 |
| ▸ | CA2 | P00918 | 3/20 | 0.84 |
| ▸ | CA4 | P22748 | 3/20 | 0.84 |
| ▸ | CA6 | P23280 | 3/20 | 0.84 |
| ▸ | CA7 | P43166 | 3/20 | 0.84 |
| ▸ | CA9 | Q16790 | 3/20 | 0.84 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.84 |
| ▸ | CA3 | P07451 | 2/20 | 0.84 |
| ▸ | CA5A | P35218 | 2/20 | 0.84 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.84 |
| ▸ | PKM | P14618 | 1/20 | 0.84 |
| ▸ | TPMT | P51580 | 5/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30615314 | 1.00 | PTGS2 (1.00) | PTGS2CA12CA1CA2CA4 | |
| Syringic Acid SCHEMBL6072775 | 0.96 | PTGS2 (0.92) | PTGS2CA12CA1CA2CA4 | |
| Syringic Acid SCHEMBL42751 | 0.91 | CA12 (1.00) | PTGS2CA12CA1CA2CA4 | |
| Syringic Acid SCHEMBL27602358 | 0.91 | CA12 (1.00) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL29913216 | 0.91 | PTGS2 (0.83) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL22824549 | 0.91 | PTGS2 (0.83) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL24614012 | 0.89 | POLB (0.81) | PTGS2CA12CA1CA2CA4 | |
| Syringic Acid SCHEMBL27832093 | 0.89 | PKM (0.96) | PTGS2CA12CA1CA2CA4 | |
| Syringic Acid SCHEMBL30250854 | 0.89 | PKM (0.96) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL6072772 | 0.88 | POLB (0.78) | PTGS2CA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125731-A1 | MICROORGANISMS AND METHODS FOR PRODUCING CAROTENOIDS AND OTHER COMPOUNDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2026-05-07 | — | — | US | claimed |
| EP-4168255-B1 | ELASTOMERIC COMPOSITION COMPRISING A PHENOLIC COMPOUND AND A COMPOUND FROM THE MONOSACCHARIDE FAMILY | MICHELIN & CIE (FR) | 2026-03-04 | — | — | EP | claimed |
| CN-120022318-A | Application of white leaf single cluster tea and active ingredients thereof in uric acid reduction | 华南农业大学 | 2025-05-23 | — | — | CN | claimed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | claimed |
| CN-119081041-A | Polyacetal prepared from formaldehyde and anhydride by copolymerization and preparation method thereof | 浙江大学 | 2024-12-06 | — | — | CN | claimed |
| US-20240350574-A1 | PHENOLIC PHYTOCHEMICALS FOR BONE METASTASIS OF CANCER | NDSU RESEARCH FOUNDATION | 2024-10-24 | — | — | US | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| US-11807873-B2 | Conversion of S-lignin compounds to useful intermediates | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-11-07 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4230201-A1 | COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-23 | — | — | EP | claimed |
| US-20130150395-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2013-06-13 | — | — | US | claimed |
| WO-2013063204-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2013-05-02 | — | — | WO | claimed |
| WO-2013016668-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | KEMPHARM INC. (US) | 2013-01-31 | — | — | WO | claimed |
| US-20120142719-A1 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | ALTER DOMUS (US) LLC | 2012-06-07 | — | — | US | claimed |
| CN-102480959-A | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | KEMPHARM INC | 2012-05-30 | — | — | CN | claimed |
| US-20120123171-A1 | Catalytic reduction of lignin acids and substituted aliphatic carboxylic acid compounds | CARTER TECHNOLOGIES (US) | 2012-05-17 | — | — | US | claimed |
| EP-2448407-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | Kempharm, Inc. (US) | 2012-05-09 | — | — | EP | claimed |
| US-20110002990-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | ALTER DOMUS (US) LLC | 2011-01-06 | — | — | US | claimed |
| EP-1157693-A1 | USE OF EPIGALLOCATECHIN 3-O-(3-O-METHYL) GALLATE AND/OR EPIGALLOCATECHIN 3-O-(4-O-METHYL) GALLATE FOR THE TREATMENT OF ALLERGY AND/OR INFLAMMATION | National Agricultural Research Organisation (NARO) (JP) | 2001-11-28 | — | — | EP | claimed |
| US-4756950-A | Support, heat meltable ink layer comprising dye, saturated polyester | MITSUBISHI PAPER MILLS, LTD. (JP) | 1988-07-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | PTGS2 1209/4885CA12 1814/4885CA1 1503/4885 |
| US-20260125731-A1 | MICROORGANISMS AND METHODS FOR PRODUCING CAROTENOIDS AND OTHER COMPOUNDS | DHPS, DCXR, BLVRB | PTGS2 541/4885CA12 3361/4885CA1 3604/4885 |
| US-20110002990-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | CYP2B6, CYP3A43, CYP2D6 | PTGS2 599/4885CA12 2215/4885CA1 1685/4885 |
| US-20120142719-A1 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | CYP2B6, CYP3A43, CYP2D6 | PTGS2 599/4885CA12 2215/4885CA1 1685/4885 |
| US-20130150395-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | OPRM1, OPRK1, CYP2D6 | PTGS2 850/4885CA12 1872/4885CA1 1329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.